Erratum: Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

Mol Ther Oncolytics. 2023 Oct 11:31:100735. doi: 10.1016/j.omto.2023.100735. eCollection 2023 Dec 19.

Abstract

[This corrects the article DOI: 10.1016/j.omto.2023.100728.].

Publication types

  • Published Erratum